Company Description
Helping people breathe and sleep properly are the core of Sepracor's business. The company focuses its drug development efforts in two main...
Key Sepracor Financials
| Company Type | Public - NASDAQ (GS): SEPR Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $1,225.2 |
| 2007 Employees | 2,277 |
More Sepracor Financials (11 pages)
Latest Sepracor Jobs jobs by Indeed
Rankings
- S&P 400
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Sepracor's competition across multiple industries
Top Sepracor Competitors
Sponsored Links
The Business Directory
Sepracor Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Timothy J. Barberich | Network | E-mail |
| EVP and CFO | Robert F. (Bob) Scumaci | Network | E-mail |
| EVP and Chief Commercial Officer | Mark Iwicki | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Sepracor News
- SOLID FORMS COMPRISING (-) O-DESMETHYLVENLAFAXINE AND USES THEREOF [PCT Biblio Info] (17 Nov 2008 16:21:00 EST)
- Peptidomimetic ligands for cellular receptors and ion channels [U.S. Patents] (11 Nov 2008 14:01:00 EST)
- BioWorld Today November 11, 2008 [BioWorld Today] (11 Nov 2008 00:01:00 EST)
Sponsored Opportunity
